Hilleman Laboratories was established as an equal joint venture by MSD and Wellcome Trust in 2009, located in New Delhi, India. Hilleman Labs is a global vaccine R & D organisation committed to developing high impact, affordable vaccines for people in developing countries. Its translational research focuses on creating safe, affordable vaccines and delivery solutions that are highly effective and can be easily incorporated into immunisation programs. Hilleman Lab’s focus is on transforming ideas into products and technologies through translational R&D and by building partnerships with vaccine manufacturers. To date, its emphasis has been largely on vaccines against infectious diseases and innovative delivery technologies for low and middle-income countries.
Follow us on Twitter: https://twitter.com/hillemanlabs